Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study

Abstract

This analysis demonstrates the magnitude of subclinical atheromatous disease in a large CKD population. The patient characteristics associated with the presence of plaque differ in every CKD stage.